Eversept Partners, LP
An institutional investment manager in NEW YORK, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1697013.
- Reported value$1.93bn
- Positions120
Holdings: 120 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| United Therapeutics Corp DelUTHR | COM | 91307C102 | 156 | 8.1% | 287,668 | Added+23,397 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 122 | 6.3% | 913,880 | Reduced−20,543 | |
| Encompass Health CorpEHC | COM | 29261A100 | 104 | 5.4% | 1,026,919 | Added+832,815 | |
| Ensign Group IncENSG | COM | 29358P101 | 96.5 | 5.0% | 602,079 | Added+587,318 | |
| Vera Therapeutics IncVERA | CL A | 92337R101 | 94.9 | 4.9% | 2,212,770 | Added+39,484 | |
| Invesco QQQ TR | UNIT SER 1 | 46090E103 | 72.6 | 3.8% | 98,600 | Put | Reduced−140,100 |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 66.5 | 3.4% | 1,785,941 | Reduced−2,075 | |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 61.2 | 3.2% | 2,798,210 | Reduced−87,412 | |
| Brookdale SR Living IncBKD | COM | 112463104 | 54.6 | 2.8% | 3,396,470 | Reduced−172,085 | |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 52.7 | 2.7% | 664,684 | Added+32,584 | |
| Natera IncNTRA | COM | 632307104 | 47.7 | 2.5% | 175,807 | Reduced−208,906 | |
| Travere Therapeutics IncTVTX | COM | 89422G107 | 45.4 | 2.4% | 798,973 | Added+256,363 | |
| Caretrust REIT IncCTRE | COM | 14174T107 | 43.3 | 2.2% | 1,072,015 | New+1,072,015 | |
| HCA Healthcare IncHCA | COM | 40412C101 | 38.3 | 2.0% | 98,252 | Added+19,023 | |
| Vaxcyte IncPCVX | COM | 92243G108 | 36.6 | 1.9% | 629,952 | Reduced−294,241 | |
| Liquidia CorporationLQDA | COM NEW | 53635D202 | 34.2 | 1.8% | 428,652 | Reduced−248,740 | |
| Community Health Sys Inc NewCYH | COM | 203668108 | 26.3 | 1.4% | 7,864,575 | Reduced−812,706 | |
| GSK plcGSK | SPONSORED ADR | 37733W204 | 25.3 | 1.3% | 481,833 | Reduced−1,303,342 | |
| Chemed Corp NewCHE | COM | 16359R103 | 24.5 | 1.3% | 52,523 | Added+21,466 | |
| ELI Lilly & CoLLY | COM | 532457108 | 24.1 | 1.3% | 20,116 | Added+1,116 | |
| Geron CorpGERN | COM | 374163103 | 24.0 | 1.2% | 18,717,422 | Reduced−117,461 | |
| Viking Therapeutics IncVKTX | COM | 92686J106 | 23.5 | 1.2% | 602,922 | Added+363,812 | |
| Omega Healthcare Invs IncOHI | COM | 681936100 | 23.1 | 1.2% | 483,547 | Reduced−102,133 | |
| Insulet CorpPODD | COM | 45784P101 | 22.7 | 1.2% | 148,816 | Added+5,270 | |
| Tenet Healthcare CorpTHC | COM NEW | 88033G407 | 21.4 | 1.1% | 114,199 | Added+84,687 | |
| Unitedhealth Group IncUNH | COM | 91324P102 | 21.3 | 1.1% | 51,145 | New+51,145 | |
| Welltower IncWELL | COM | 95040Q104 | 19.8 | 1.0% | 87,312 | Reduced−93,641 | |
| Beta Bionics IncBBNX | COM | 08659B102 | 19.6 | 1.0% | 1,249,441 | Reduced−165,397 | |
| Cogent Biosciences IncCOGT | COM | 19240Q201 | 19.0 | 1.0% | 490,235 | New+490,235 | |
| Biocryst Pharmaceuticals IncBCRX | COM | 09058V103 | 18.7 | 1.0% | 1,865,653 | Reduced−1,174,167 | |
| Molina Healthcare IncMOH | COM | 60855R100 | 18.4 | 1.0% | 80,594 | Added+47,783 | |
| Pennant Group IncPNTG | COM | 70805E109 | 17.0 | 0.9% | 460,272 | Added+148,094 | |
| LTC Pptys IncLTC | COM | 502175102 | 16.2 | 0.8% | 420,640 | Added+99,594 | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 15.9 | 0.8% | 149,209 | New+149,209 | |
| Viridian Therapeutics IncVRDN | COM | 92790C104 | 15.3 | 0.8% | 831,142 | Added+117,873 | |
| Biomarin Pharmaceutical IncBMRN | COM | 09061G101 | 14.3 | 0.7% | 249,607 | Added+41,839 | |
| AMN Healthcare SVCS IncAMN | COM | 001744101 | 13.9 | 0.7% | 428,531 | New+428,531 | |
| Celcuity IncCELC | COM | 15102K100 | 13.4 | 0.7% | 127,931 | New+127,931 | |
| Pharvaris N V | COM | N69605108 | 13.4 | 0.7% | 386,383 | Reduced−20,577 | |
| Cytomx Therapeutics Inc.CTMX | COM | 23284F105 | 13.3 | 0.7% | 3,558,497 | Added+369,983 | |
| Humana IncHUM | COM | 444859102 | 12.4 | 0.6% | 31,171 | New+31,171 | |
| Xenon Pharmaceuticals IncXENE | COM | 98420N105 | 11.9 | 0.6% | 196,532 | Added+66,958 | |
| Corvus Pharmaceuticals IncCRVS | COM | 221015100 | 11.2 | 0.6% | 747,994 | New+747,994 | |
| Ascendis Pharma A/S | ORD SHS | K08588103 | 11.1 | 0.6% | 41,621 | New+41,621 | |
| Bruker CorpBRKR | COM | 116794108 | 11.0 | 0.6% | 182,894 | Added+65,881 | |
| Moderna IncMRNA | COM | 60770K107 | 10.7 | 0.6% | 152,122 | Reduced−7,586 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 10.5 | 0.5% | 196,302 | Added+58,266 | |
| Insmed IncINSM | COM PAR $.01 | 457669307 | 10.3 | 0.5% | 96,600 | Call | Added+2,600 |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 10.2 | 0.5% | 217,185 | Added+56,462 | |
| Compass Pathways plcCMPS | SPONSORED ADS | 20451W101 | 9.5 | 0.5% | 672,825 | Reduced−5,099 | |
| Newamsterdam Pharma Company | ORDINARY SHARES | N62509109 | 9.3 | 0.5% | 275,471 | Reduced−10,293 | |
| Revvity IncRVTY | COM | 714046109 | 9.3 | 0.5% | 83,624 | Reduced−1,230 | |
| Palisade Bio IncPALI | COM | 696389402 | 8.7 | 0.5% | 4,182,785 | Reduced−804,714 | |
| Ardelyx IncARDX | COM | 039697107 | 8.6 | 0.4% | 1,678,345 | Reduced−551,101 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 8.4 | 0.4% | 309,689 | New+309,689 | |
| Relay Therapeutics IncRLAY | COM | 75943R102 | 8.1 | 0.4% | 434,314 | Added+163,609 | |
| Novo-Nordisk a SNVO | ADR | 670100205 | 8.1 | 0.4% | 169,227 | New+169,227 | |
| Biohaven Ltd | COM | G1110E107 | 7.7 | 0.4% | 515,804 | New+515,804 | |
| Protagonist Therapeutics IncPTGX | COM | 74366E102 | 7.2 | 0.4% | 58,504 | New+58,504 | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 6.9 | 0.4% | 136,631 | New+136,631 | |
| Replimune Group IncREPL | COM | 76029N106 | 6.5 | 0.3% | 590,252 | Added+255,391 | |
| LB Pharmaceuticals IncLBRX | COM SHS | 50180M108 | 6.0 | 0.3% | 183,663 | Added+83,465 | |
| Beam Therapeutics IncBEAM | COM | 07373V105 | 5.7 | 0.3% | 166,289 | New+166,289 | |
| National Health Invs IncNHI | COM | 63633D104 | 5.4 | 0.3% | 70,673 | New+70,673 | |
| Ultragenyx Pharmaceutical inRARE | COM | 90400D108 | 5.1 | 0.3% | 154,130 | Added+91,555 | |
| Pacs Group IncPACS | COM SHS | 69380Q107 | 5.0 | 0.3% | 117,441 | New+117,441 | |
| SPDR Series Trust | ST STR SP BIOT | 78464A870 | 4.9 | 0.3% | 31,000 | Put | Added+1,000 |
| Equillium IncEQ | COM | 29446K106 | 4.9 | 0.3% | 1,520,824 | Added+21,831 | |
| Anaptysbio IncANAB | COM | 032724106 | 4.7 | 0.2% | 69,983 | Added+42,894 | |
| National Healthcare CorpNHC | COM | 635906100 | 4.7 | 0.2% | 22,116 | New+22,116 | |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 4.3 | 0.2% | 297,735 | New+297,735 | |
| Sonida Senior Living IncSNDA | COM | 140475203 | 4.2 | 0.2% | 102,624 | Added+74,187 | |
| Glaukos CorpGKOS | COM | 377322102 | 4.1 | 0.2% | 29,343 | Reduced−30,871 | |
| Agilon Health IncAGL | COM NEW | 00857U206 | 4.1 | 0.2% | 37,792 | Reduced−138,796 | |
| Arcutis Biotherapeutics IncARQT | COM | 03969K108 | 3.5 | 0.2% | 135,355 | Reduced−441,225 | |
| Tarsus Pharmaceuticals IncTARS | COM | 87650L103 | 3.5 | 0.2% | 55,710 | New+55,710 | |
| Alto Neuroscience IncANRO | COM SHS | 02157Q109 | 3.4 | 0.2% | 128,286 | Added+3,118 | |
| ARS Pharmaceuticals IncSPRY | COM | 82835W108 | 3.0 | 0.2% | 377,007 | Added+240,772 | |
| Inflarx NV | COM | N44821101 | 2.9 | 0.2% | 1,304,069 | Reduced−454,504 | |
| Intuitive Surgical IncISRG | COM NEW | 46120E602 | 2.9 | 0.1% | 7,241 | Reduced−3,878 | |
| Alector IncALEC | COM | 014442107 | 2.9 | 0.1% | 1,423,873 | Added+72,767 | |
| Universal HLTH SVCS IncUHS | CL B | 913903100 | 2.8 | 0.1% | 18,800 | Put | Added+600 |
| VOR Biopharma IncVOR | COM NEW | 929033207 | 2.8 | 0.1% | 149,681 | New+149,681 | |
| Design Therapeutics IncDSGN | COM | 25056L103 | 2.7 | 0.1% | 190,000 | New+190,000 | |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 2.7 | 0.1% | 276,174 | Unchanged | |
| Qiagen NV | ORD SHARES | N72482156 | 2.7 | 0.1% | 68,100 | Call | Reduced−408,200 |
| PMV Pharmaceuticals IncPMVP | COM | 69353Y103 | 2.5 | 0.1% | 1,890,904 | Reduced−457,456 | |
| Contineum Therapeutics IncCTNM | CL A | 21217B100 | 2.4 | 0.1% | 148,017 | Added+1,606 | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 2.3 | 0.1% | 174,460 | Added+119,780 | |
| Amarin Corp plcAMRN | SPONSORED ADR | 023111404 | 2.3 | 0.1% | 145,296 | Reduced−2,419 | |
| Spruce Biosciences IncSPRB | COM NEW | 85209E208 | 2.2 | 0.1% | 40,000 | New+40,000 | |
| Repligen CorpRGEN | COM | 759916109 | 2.0 | 0.1% | 14,401 | Reduced−106,384 | |
| Invivyd IncIVVD | COM | 00534A102 | 2.0 | 0.1% | 2,237,015 | Reduced−39,334 | |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | 1.9 | <0.1% | 1,022,265 | New+1,022,265 | |
| Grace Therapeutics IncGRCE | COM | 00439U104 | 1.8 | <0.1% | 772,900 | Added+16,300 | |
| Anteris Technologies GlobalAVR | COM | 03675P102 | 1.6 | <0.1% | 166,229 | Reduced−234,958 | |
| VIR Biotechnology IncVIR | COM | 92764N102 | 1.6 | <0.1% | 156,636 | Reduced−93,364 | |
| Editas Medicine IncEDIT | COM | 28106W103 | 1.5 | <0.1% | 458,809 | Added+167,890 | |
| Whitehawk Therapeutics IncWHWK | COM | 00032Q104 | 1.4 | <0.1% | 303,306 | Reduced−3,494 | |
| Bio-Techne CorpTECH | COM | 09073M104 | 1.4 | <0.1% | 19,308 | Reduced−106,588 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 1.3 | <0.1% | 6,943 | New+6,943 | |
| Savara IncSVRA | COM | 805111101 | 1.3 | <0.1% | 204,428 | Reduced−179,836 | |
| Surrozen IncSRZN | COM NEW | 86889P208 | 1.2 | <0.1% | 47,777 | Reduced−10,847 | |
| Inovio Pharmaceuticals IncINO | COM SHS | 45773H409 | 1.1 | <0.1% | 1,035,360 | Unchanged | |
| Pliant Therapeutics IncPLRX | COM | 729139105 | 1.0 | <0.1% | 891,425 | Unchanged | |
| Cybin Inc | COM NEW | 23256X407 | 1.0 | <0.1% | 146,403 | New+146,403 | |
| Odyssey Therapeutics IncODTX | COMMON STOCK | 67613T104 | 0.9 | <0.1% | 49,658 | New+49,658 | |
| Engene Therapeutics IncENGN | COM | 29286X101 | 0.8 | <0.1% | 469,584 | New+469,584 | |
| Bicycle Therapeutics plcBCYC | SPONSORED ADS | 088786108 | 0.8 | <0.1% | 190,715 | Unchanged | |
| Lipocine Inc NewLPCN | COM NEW | 53630X203 | 0.8 | <0.1% | 294,989 | Unchanged | |
| Relmada Therapeutics IncRLMD | COM | 75955J402 | 0.6 | <0.1% | 93,192 | Reduced−184,707 | |
| Ehealth IncEHTH | COM | 28238P109 | 0.6 | <0.1% | 404,854 | Added+183,939 | |
| Ataibeckley Inc | COM SHS | 04650F101 | 0.5 | <0.1% | 102,430 | New+102,430 | |
| Akebia Threapeutics IncAKBA | COM | 00972D105 | 0.5 | <0.1% | 427,095 | New+427,095 | |
| SS Innovations InternationalSSII | COM NEW | 05453U203 | 0.5 | <0.1% | 110,157 | Unchanged | |
| Assembly Biosciences IncASMB | COM NEW | 045396207 | 0.5 | <0.1% | 16,510 | Reduced−24,379 | |
| Retractable Technologies IncRVP | COM | 76129W105 | 0.4 | <0.1% | 580,919 | Unchanged | |
| Selectquote IncSLQT | COM | 816307300 | 0.3 | <0.1% | 319,788 | Reduced−37,873 | |
| GH Research plc | ORDINARY SHARES | G3855L106 | 0.2 | <0.1% | 8,672 | New+8,672 | |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 0.2 | <0.1% | 10,000 | New+10,000 |
Sold out: 32 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals IncAGIO | COM | 00847X104 | 0.0 | 0.0% | 0 | Sold out−200,000 | |
| Airsculpt Technologies IncAIRS | COM | 009496100 | 0.0 | 0.0% | 0 | Sold out−74,139 | |
| Avantor IncAVTR | COM | 05352A100 | 0.0 | 0.0% | 0 | Sold out−2,974,287 | |
| Bioventus IncBVS | COM CL A | 09075A108 | 0.0 | 0.0% | 0 | Sold out−159,110 | |
| Centene Corp DelCNC | COM | 15135B101 | 0.0 | 0.0% | 0 | Sold out−111,652 | |
| DAY One Biopharmaceuticals I | COM | 23954D109 | 0.0 | 0.0% | 0 | Sold out−183,902 | |
| Diversified Healthcare TRDHC | COM SH BEN INT | 25525P107 | 0.0 | 0.0% | 0 | Sold out−151,283 | |
| Engene Holdings Inc | COM | 29286M105 | 0.0 | 0.0% | 0 | Sold out−510,543 | |
| Enhabit Inc | COM | 29332G102 | 0.0 | 0.0% | 0 | Sold out−227,451 | |
| Esperion Therapeutics Inc Ne | COM | 29664W105 | 0.0 | 0.0% | 0 | Sold out−1,735,963 | |
| Healthequity IncHQY | COM | 42226A107 | 0.0 | 0.0% | 0 | Sold out−51,614 | |
| Healthpeak Properties IncDOC | COM | 42250P103 | 0.0 | 0.0% | 0 | Sold out−1,981,070 | |
| Icon plc | SHS | G4705A100 | 0.0 | 0.0% | 0 | Sold out−68,688 | |
| Immunocore Holdings plcIMCR | ADS | 45258D105 | 0.0 | 0.0% | 0 | Sold out−39,238 | |
| Inmode Ltd | SHS | M5425M103 | 0.0 | 0.0% | 0 | Sold out−67,744 | |
| Ishares TR | IBOXX HI YD ETF | 464288513 | 0.0 | 0.0% | 0 | Put | Sold out−180,000 |
| Ishares TR | 20 YR TR BD ETF | 464287432 | 0.0 | 0.0% | 0 | Put | Sold out−428,800 |
| Ishares TR | RUSSELL 2000 ETF | 464287655 | 0.0 | 0.0% | 0 | Put | Sold out−40,000 |
| Karyopharm Therapeutics IncKPTI | COM NEW | 48576U205 | 0.0 | 0.0% | 0 | Call | Sold out−23,800 |
| Madrigal Pharmaceuticals IncMDGL | COM | 558868105 | 0.0 | 0.0% | 0 | Sold out−10,000 | |
| Novocure Ltd | ORD SHS | G6674U108 | 0.0 | 0.0% | 0 | Sold out−134,917 | |
| Passage Bio IncPASG | COM NEW | 702712209 | 0.0 | 0.0% | 0 | Sold out−131,581 | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 0.0 | 0.0% | 0 | Put | Sold out−14,800 |
| Qiagen NV | ORD SHARES | N72482156 | 0.0 | 0.0% | 0 | Sold out−545,330 | |
| Replimune Group IncREPL | COM | 76029N106 | 0.0 | 0.0% | 0 | Call | Sold out−52,000 |
| Select Sector SPDR TR | STATE STREET ENE | 81369Y506 | 0.0 | 0.0% | 0 | Call | Sold out−50,000 |
| Select Sector SPDR TR | STATE STREET TEC | 81369Y803 | 0.0 | 0.0% | 0 | Put | Sold out−70,000 |
| State STR SPDR S&P 500 ETF TSPY | TR UNIT | 78462F103 | 0.0 | 0.0% | 0 | Put | Sold out−107,000 |
| Sutro Biopharma IncSTRO | COM SHS | 869367201 | 0.0 | 0.0% | 0 | Sold out−73,161 | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 0.0 | 0.0% | 0 | Sold out−27,055 | |
| Unitedhealth Group IncUNH | COM | 91324P102 | 0.0 | 0.0% | 0 | Call | Sold out−40,000 |
| Vertex Pharmaceuticals IncVRTX | COM | 92532F100 | 0.0 | 0.0% | 0 | Call | Sold out−90,000 |
Source: SEC EDGAR, Form 13F-HR, accession 0001697013-26-000005 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.